MedTrace Logo

Pilot Study to Determine the Optimal Negative Pressure for Non-invasive Breast Augmentation in Women

NCT04185961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-05-20

No results posted yet for this study

Summary

Aim is to investigate optimum pressure and evaluate safety and effectiveness of EVERA-RAPHA for breast augmentation

Conditions

  • Breast Hypoplasia

Interventions

DEVICE

EVERA-RAPHA with 60mmHG

Apply EVERA-RAPHA with 60mmHG for 4weeks

DEVICE

EVERA-RAPHA with 100mmHG

Apply EVERA-RAPHA with 100mmHG for 4weeks

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chan Yeong Heo, Doctor · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2020-03-30
Completion
2020-04-06

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185961 on ClinicalTrials.gov